Host nuclear factor-κB activation potentiates lung cancer metastasis

被引:51
|
作者
Stathopoulos, Georgios T. [2 ]
Sherrill, Taylor P. [2 ]
Han, Wei [2 ]
Sadikot, Fluxana T. [2 ]
Yull, Fiona E. [1 ]
Blackwell, Timothy S. [1 ,2 ,3 ]
Fingleton, Barbara [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA
[3] VA Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA
关键词
D O I
10.1158/1541-7786.MCR-07-0309
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiologic and experimental evidence suggests that a link exists between inflammation and cancer, although this relationship has only recently begun to be elucidated for lung cancer, the most frequently fatal human tumor. Nuclear factor-kappa B (NF-kappa B), a transcription factor that controls innate immune responses in the lungs, has been implicated as an important determinant of cancer cell proliferative and metastatic potential; however, its role in lung tumorigenesis is uncertain. Here, we specifically examine the role of NF-kappa B-induced airway inflammation in lung cancer metastasis using a model of intravenous injection of Lewis lung carcinoma cells into immunocompetent C57BI/6 mice. Induction of lung inflammation by direct and specific NF-kappa B activation in airway epithelial cells potentiates lung adenocarcinoma metastasis. Moreover, we identify resident lung macrophages as crucial effectors of lung susceptibility to metastatic cancer growth. We conclude that NF-kappa B activity in host tissue is a significant factor in the development of lung metastasis.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 50 条
  • [21] Activation of nuclear factor-κB in dogs with chronic enteropathies
    Luckschander, Nicole
    Hall, Jean A.
    Gaschen, Frederic
    Forster, Ursula
    Wenzlow, Nanny
    Hermann, Pascal
    Allenspach, Karin
    Dobbelaere, Dirk
    Burgener, Iwan A.
    Welle, Monika
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2010, 133 (2-4) : 228 - 236
  • [22] Nuclear factor-κB activation:: A question of life or death
    Shishodia, S
    Aggarwal, BB
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 35 (01): : 28 - 40
  • [23] Stereospecific induction of nuclear factor-κB activation by isochamaejasmin
    Tian, QH
    Li, J
    Xie, X
    Sun, ML
    Sang, HR
    Zhou, CH
    An, TY
    Hu, LH
    Ye, RD
    Wang, MW
    MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1534 - 1542
  • [24] Inhibition of nuclear factor-κB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells
    Starenki, D
    Namba, H
    Saenko, V
    Ohtsuru, A
    Yamashita, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01): : 410 - 418
  • [25] Nuclear factor-κB activation in human testicular apoptosis
    Pentikäinen, V
    Suomalainen, L
    Erkkilä, K
    Martelin, E
    Parvinen, M
    Pentikäinen, MO
    Dunkel, L
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01): : 205 - 218
  • [26] Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin
    Granville, DJ
    Carthy, CM
    Jiang, H
    Levy, JG
    McManus, BM
    Matroule, JY
    Piette, J
    Hunt, DWC
    BLOOD, 2000, 95 (01) : 256 - 262
  • [27] Signaling pathways leading to nuclear factor-κB activation
    Li, NX
    Karin, M
    SINGLET OXYGEN, UV-A, AND OZONE, 2000, 319 : 273 - 279
  • [28] Nuclear factor-κB activation in alveolar macrophages requires Iκkinase-β, but not nuclear factor-κB inducing kinase
    Conron, M
    Andreakos, E
    Pantelidis, P
    Smith, C
    Beynon, HLC
    Dubois, RM
    Foxwell, BMJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 996 - 1004
  • [29] Nuclear factor-κB is upregulated in colorectal cancer
    Lind, DS
    Hochwald, SN
    Malaty, J
    Rekkas, S
    Hebig, P
    Mishra, G
    Moldawer, LL
    Copeland, EM
    MacKay, S
    SURGERY, 2001, 130 (02) : 363 - 369
  • [30] Nuclear factor-κB in cancer development and progression
    Michael Karin
    Nature, 2006, 441 : 431 - 436